Login / Signup

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.

Teresa Po-Yu ChiangCaoilfhionn Marie ConnollyJake A RuddyBrian J BoyarskyJennifer L AlejoWilliam A WerbelAllan MassieLisa Christopher-StineJacqueline Garonzik-WangDorry L SegevJulie J Paik
Published in: Annals of the rheumatic diseases (2021)
Keyphrases
  • sars cov
  • rheumatoid arthritis
  • respiratory syndrome coronavirus